Chronic Kidney Disease (CKD) https://greenmedinfo.com/category/keywords/Chronic%20Kidney%20Disease%20%28CKD%29 en Moderate protein restriction in a vegan-vegetarian supplemented diet is confirmed as a safe option in the management of pregnant CKD patients. https://greenmedinfo.com/article/moderate-protein-restriction-vegan-vegetarian-supplemented-diet-confirmed-safe n/a PMID:  BMC Nephrol. 2016 Sep 20 ;17(1):132. Epub 2016 Sep 20. PMID: 27649693 Abstract Title:  Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience. Abstract:  BACKGROUND: Pregnancy in women with advanced CKD becoming increasingly common. However, experience with low-protein diets in CKD patients in pregnancy is still limited. Aim of this study is to review the results obtained over the last 15 years with moderately restricted low-protein diets in pregnant CKD women (combining: CKD stages 3-5, proteinuria: nephrotic at any time, or > =1 g/24 at start or referral; nephrotic in previous pregnancy). CKD patients on unrestricted diets were employed for comparison. METHODS: STUDY PERIOD: January, 2000 to September, 2015: 36 on-diet pregnancies (31 singleton deliveries, 3 twin deliveries, 1 pregnancy termination, 1 miscarriage); 47 controls (42 singleton deliveries, 5 miscarriages). The diet is basically vegan; since occasional milk and yoghurt are allowed, we defined it vegan-vegetarian; protein intake (0.6-0.8 g/Kg/day), keto-acid supplementation, protein-unrestricted meals (1-3/week) are prescribed according to CKD stage and nutritional status. Statistical analysis was performed as implemented on SPSS. RESULTS: Patients and controls were similar (p: ns) at baseline with regard to age (33 vs 33.5), referral week (7 vs 9), kidney function (CKD 3-5: 48.4 % vs 64.3 %); prevalence of hypertension (51.6 % vs 40.5 %) and proteinuria>3 g/24 h (16.1 % vs 12.2 %). There were more diabetic nephropathies in on-diet patients (on diet: 31.0 % vs controls 5.3 %; p 0.007 (Fisher)) while lupus nephropathies were non-significantly higher in controls (on diet: 10.3 % vs controls 23.7 %; p 0.28 (Fisher)). The incidence of preterm delivery was similar (<37 weeks: on-diet singletons 77.4 %; controls: 71.4 %). The incidence of other adverse pregnancy related outcomes was non-significantly lower in on-diet patients (early preterm delivery: on diet: 32.3 % vs controls 35.7 %; birth-weight = <1.500 g: on diet: 9.7 % vs controls 23.8 %). None of the singletons in the on-diet series died, while two perinatal deaths occurred among the controls (p = 0.505). The incidence of small for gestational age (SGA<10th centile) and/or extremely preterm babies (<28th week) was significantly lower in singletons from on-diet mothers than in controls (on diet: 12.9 % vs controls: 33.3 %; p: 0.04 (Fisher)). CONCLUSION: Moderate protein restriction in the context of a vegan-vegetarian supplemented diet is confirmed as a safe option in the management of pregnant CKD patients. https://greenmedinfo.com/article/moderate-protein-restriction-vegan-vegetarian-supplemented-diet-confirmed-safe#comments Chronic Kidney Disease (CKD) Dietary Modification: Vegan Diet Dietary Modification: Vegetarian Chronic Kidney Disease (CKD) Pregnancy pregnant women Vegan vegetarian women's health Human Study Thu, 22 Dec 2016 17:23:51 +0000 greenmedinfo 140847 at https://greenmedinfo.com Six months yoga program is safe and effective as an adjuvant therapy in improving renal functions and QOL of CKD patients. https://greenmedinfo.com/article/six-months-yoga-program-safe-and-effective-adjuvant-therapy-improving-renal-fu n/a PMID:  Int J Yoga. 2017 Jan-Apr;10(1):3-8. PMID: 28149061 Abstract Title:  Effects of 6 months yoga program on renal functions and quality of life in patients suffering from chronic kidney disease. Abstract:  AIM: To study the effect of 6 months yoga program in patients suffering from chronic kidney disease (CKD). MATERIALS AND METHODS: Fifty-four patients with CKD were studied and divided into two groups (yoga group and control group) to see the effect of yoga in CKD. Patients in the yoga group were offered yoga therapy along with other conventional treatment modalities, while the control group was only on conventional treatment. Subjects in yoga group were trained to perform specific yogic asanas for at least 5 days a week for 40-60 min a day. Regular monitoring of blood pressure, renal function, requirement of a number of dialysis, and quality of life (QOL) indicators were done. Fifty patients (yoga - 25; control-25) completed 6 months follow-up. RESULTS: In yoga group, a significant reduction of systolic and diastolic blood pressure, significant reduction in blood urea and serum creatinine levels, and significant improvement in physical and psychological domain of the World Health Organization QOL (as assessed by BREF QOL scores) were seen after 6 months. In control group, rise of blood pressure, deterioration of renal function, and QOL were observed. Poststudy comparison between the two groups showed a statistically significant reduction of blood pressure, nonsignificant reduction in blood urea and serum creatinine, and significant improvement in physical and psychological domain of QOL in yoga group as compared to control group. For subjects in yoga group, the need for dialysis was less when compared to control group although this difference was statistically insignificant. Except for inability of some patients to perform certain yogic asanas no adverse effect was found in the study. CONCLUSION: Six months yoga program is safe and effective as an adjuvant therapy in improving renal functions and QOL of CKD patients. https://greenmedinfo.com/article/six-months-yoga-program-safe-and-effective-adjuvant-therapy-improving-renal-fu#comments Chronic Kidney Disease (CKD) Quality of Life: Poor Antihypertensive Agents Antihypertensive Agents Chronic Kidney Disease (CKD) Quality of Life: Poor yoga Human Study Wed, 08 Mar 2017 02:25:01 +0000 greenmedinfo 144514 at https://greenmedinfo.com